Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan

By sjmartinez • January 20, 2024

Tangri N, Rastogi A, Nekeman-Nan C, Hong LS, Ozaki A, Franzén S, Sofue T. Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan. Adv Ther. 2024 Jan 19. doi: 10.1007/s12325-023-02773-x. Epub ahead of print. PMID: 38240949.

Tags: Chronic kidney disease, dapagliflozin, effectiveness, Epidemiology, Nephrology, Publications, SGLT2I

Challenges and potential solutions to enrollment in a clinical trial of arteriovenous fistula vs arteriovenous graft vascular access strategy

Goldman MP, Patel DM, Chang KZ, Davis RP, Edwards MS, Hurie JB, Sutsrim A, Velazquez-Ramirez G, Williams TK, Grandas OH, Freeman MB, McNally MM, Stevens[...]

Advances in Organoid Research and Developmental Engineering

Hauser PV. Advances in Organoid Research and Developmental Engineering. Bioengineering (Basel). 2024 Dec 15;11(12):1275. doi: 10.3390/bioengineering11121275. PMID: 39768093.

Antiplasma cell antibodies: A new era of human leukocyte antigen antibody control in solid organ transplantation

Chandran S, Vincenti F. Antiplasma cell antibodies: A new era of human leukocyte antigen antibody control in solid organ transplantation. Am J Transplant. 2025 Jan;25(1):19-26.[...]